Concepedia

Publication | Open Access

Effects of Luseogliflozin on Estimated Plasma Volume in Patients with Heart Failure with Preserved Ejection Fraction

DOIFull Paper Access

10

Citations

30

References

2021

Year

M Nakashima, Toru Miyoshi, Kentaro Ejiri, Hajime Kihara, Yoshiki Hata, Toshihiko Nagano, Atsushi Takaishi, H. Toda, Seiji Nanba, Yoichi Nakamura,
ESC Heart Failure

Abstract

Luseogliflozin significantly reduced ePV in patients with type 2 diabetes and HFpEF, as compared with voglibose. The reduction of intravascular volume by luseogliflozin may provide clinical benefits to patients with type 2 diabetes and HFpEF.

References

YearCitations

Page 1